This article relies largely or entirely on a single source . Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "3,4-Methylenedioxy-N-isopropylamphetamine" – news · newspapers · books · scholar · JSTOR (August 2016) |
![]() | |
Names | |
---|---|
Preferred IUPAC name 1-(2H-1,3-Benzodioxol-5-yl)-N-(propan-2-yl)propan-2-amine | |
Other names 3,4-Methylenedioxy-N-isopropylamphetamineamine 3,4-Methylenedioxy-1-(alpha-methyl-amino-isopropyl)-ethane | |
Identifiers | |
3D model (JSmol) | |
ChemSpider | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C13H19NO2 | |
Molar mass | 221.300 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
3,4-Methylenedioxy-N-isopropylamphetamine (MDIP, MDIPA) is a psychoactive drug of the phenethylamine and amphetamine chemical classes. It is the N-isopropyl analogue of 3,4-methylenedioxyamphetamine (MDA). MDIP was first synthesized by Alexander Shulgin. In his book PiHKAL , the minimum dosage is listed as 250 mg. [1] MDIP produces a mild threshold. Very little is known about the pharmacology, pharmacokinetics, effects, and toxicity of MDIP.
![]() | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |